Michael Hallek

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Michael Hallek

Sep 2, 2024, 03:14 | Insight

Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials

Othman Al-Sawaf, Haematologist and Medical Oncologist at the University Hospital Cologne, Cologne, Germany, shared a…

Aug 12, 2024, 22:14 | Blog

Exercise reduces CIPN during Chemotherapy

Alessandro Samuelly, Medical oncologist at the University of Turin, shared on X: "Great results from…

Aug 1, 2024, 03:07 | Insight

PET-adapted BrECADD versus escBEACOPP in Hodgkin Lymphoma

Graham Collins, Associate Professor, Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared…

Jul 16, 2024, 07:54 | Blog

Michael Hallek: PET-guided BrECADD versus eBEACOPP in Hodgkin lymphoma

Michael Hallek, Director of Clinic I for Internal Medicine and Associated Principle Investigator at the University…

Jul 8, 2024, 12:42 | Insight

Neuromuscular Training on Chemotherapy-Induced Neuropathy

Osama Mosalem, a Hematology Oncology fellow at Mayo Clinic, shared a post on X: "Exercise…

Jul 2, 2024, 14:23 | Blog

8th Translational Research Conference on Lymphoid malignancies - European School of Haematology

European School of Haematology shared on X: "ESHLYMPHOID2025: MARK YOUR AGENDA, NEW DATE: October 2-4, 2025…

Jun 19, 2024, 15:08 | Blog

Always great to meet you, Michael Hallek - ESH

ESH (Haematology) shared a post by Michael Hallek, Director of Clinic I for Internal Medicine…

All: 7 Posts: 1 - 100